Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Journal of Clinical Oncology

Outcomes of patients with bone marrow fibrosis in de novo and secondary acute myeloid leukemia.

View Full Paper
Ask AI
Bookmark
Share

Authors

SUSamuel UrrutiaThe University of Texas MD Anderson Cancer Center
Hagop M. Kantarjian
Hagop M. KantarjianThe University of Texas MD Anderson Cancer CenterFRFarhad Ravandi‐KashaniThe University of Texas MD Anderson Cancer Center

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Urrutia et al. (2024) studied this question.

synapsesocial.com/papers/68e671c0b6db6435875fbfc5https://doi.org/10.1200/jco.2024.42.16_suppl.6538
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Impact of bone marrow fibrosis on outcomes of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia2024 · 5 citations
  2. 2Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantation2024 · 3 citations
  3. 3The treatment of patients with chronic myeloid leukemia chronic phase combined with myelofibrosis with tyrosine kinase inhibitors: A Chinese population-based study.2024
  4. 4The Prevalence and Clinical Impact of Bone Marrow Fibrosis in Chronic Myeloid Leukemia2026
  5. 5Efficacy and prognosis of hypomethylating agent therapy in patients with myelodysplastic syndromes with bone marrow fibrosis2026